These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 458305)

  • 1. Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings].
    Delitala G; Stubbs WA; Yeo T; Jones A; Thorner MO; Besser GM
    J Endocrinol; 1979 May; 81(2):121P. PubMed ID: 458305
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.
    MacLeod RM; Lehmeyer JE
    Endocrinology; 1974 Apr; 94(4):1077-85. PubMed ID: 4818768
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR; Cross DL; Birrenkott GP; Grimes LW
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells.
    Braghiroli L; Ponzianelli A; Fiani M; De Feo G; Cheng CY; Mazzanti G
    Pharmacol Res; 1997 Mar; 35(3):173-5. PubMed ID: 9229404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide.
    Lamberts SW; MacLeod RM
    Endocrinology; 1978 Jul; 103(1):287-95. PubMed ID: 744080
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
    Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of ergot compounds with dopamine receptors and endocrine functions.
    Flückiger E
    J Neural Transm Suppl; 1983; 18():189-204. PubMed ID: 6576114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL; Danguy A; Frérotte M; Ectors F
    Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
    Wiggins JF; Sved AF; Fernstrom JD
    J Pharmacol Exp Ther; 1980 Feb; 212(2):304-8. PubMed ID: 6766188
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of prolactin secretion by metoclopramide in the rat.
    Carlson HE; Briggs JE; McCallum RW
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):475-8. PubMed ID: 847008
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR; Creese I
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct inhibition by ergocornine of pituitary prolactin release.
    Lu KH; Koch Y; Meites J
    Endocrinology; 1971 Jul; 89(1):229-33. PubMed ID: 5089657
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic modulation of nNOS expression in the pituitary gland of male rat.
    Carretero J; Weruaga E; Hernández E; Burks D; Riesco JM; Rubio M; Briñón JG; Aijón J; Vázquez R; Alonso JR
    Anat Embryol (Berl); 2003 Dec; 207(4-5):381-8. PubMed ID: 14618399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mode of action of ergocornin on the secretion of prolactin].
    Pasteels JL; Ectors F
    Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):195-6. PubMed ID: 5473176
    [No Abstract]   [Full Text] [Related]  

  • 19. The biphasic regulation of prolactin secretion by dopamine agonist-antagonists.
    MacLeod RM; Lamberts SW
    Endocrinology; 1978 Jul; 103(1):200-3. PubMed ID: 744072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological intervention on the pituitary-hypothalamic relationship.
    Tuomisto J
    Ann Clin Res; 1978; 10(3):120-32. PubMed ID: 31130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.